CV Technologies: Clinical Trials

1 trial sponsored by CV Technologies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow CV Technologies: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
CVT-E002 (Cold-FX); a natural health product - Upper Respiratory Infection
Phase 3CompletedCV Technologies5002005-12-012009-06-08

Conditions studied

Common Cold (1)  ·  Influenza, Human (1)  ·  Respiratory Tract Infections (1)

Interventions

COLD-fX (1)

Countries

Canada (1)

Top investigators

Gerry Predy, MD (1)